India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

It comes as the weight loss company had been struggling under $1.6billion (£1.2billion) of debt after losing business to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Department of Mathematics, School of Science, Research Center for Econophysics, East China University of Science and Technology, Shanghai 200237, P. R. China ...

A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...

A MUM-OF-TWO has revealed how her food addiction turned into becoming a Mounjaro addict instead. TikTok user Kharis ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

The restaurant industry may face significant changes due to new weight loss drugs like Ozempic and Mounjaro, which lead to ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

NVO stock declines 3% as the company announces that Lars Fruergaard Jorgensen will be stepping down as the CEO.